Anatomic Pathology Market - Top Companies and Manufacturers

  • Report ID: 4377
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Companies Dominating the Anatomic Pathology Landscape

top-features-companies
    • PHC Holdings Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Indica Labs, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Sakura Finetek USA, Inc.
    • Cardinal Health, Inc.
    • BioGenex
    • NeoGenomics Laboratories, Inc.
    • Agilent Technologies, Inc. 

Browse Key Market Insights with Data Illustration:

In the News

  • Epredia, - a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.

  •  Indica Labs, Inc., - with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.


Author Credits:  Radhika Pawar


  • Report ID: 4377
  • Published Date: Jun 17, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of anatomic pathology is estimated at USD 38.1 Billion.

Anatomic Pathology Market size was over USD 35.29 Billion in 2023 and is set to cross USD 99.64 Billion by the end of 2036, growing at more than 8.5% CAGR during the forecast period i.e., between 2024-2036. Increasing number of laboratory tests as well as biopsies performed along with rising cases of cancer, kidney diseases and others are some of the major factors anticipated to drive the growth of the market.

The North American region held around 39% revenue share in 2023, backed by presence of a strong healthcare network in the region

PHC Holdings Corporation, Indica Labs, Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics Laboratories, Inc., Agilent Technologies, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying